FDA Inspection 610032 — Aton Pharma Inc.

Aton Pharma Inc. — FEI 3005740291

The FDA completed an inspection of Aton Pharma Inc. on Sep 10, 2009 in Lawrenceville, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 10, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Lawrenceville, NJ (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673021 CFR 314.80(b)Failure to develop written procedures
682321 CFR 314.80(c)Failure by applicant to report ADE
683221 CFR 314.80(c)(2)Late submission of annual safety reports

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.